Showing results (101-110 of 676) with videos related to
Sort By:
Pageof 68
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2012
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimodSebastian Jander, Bernd Turowski, Bernd C Kieseier, et al.Current Opinion in Neurology|April 9, 2026
Oxidative and nitrosative damage in multiple sclerosisTim Prozorovski, Sven G Meuth, Hans-Peter Hartung, et al.Journal of the Peripheral Nervous System : JPNS|March 13, 2016
Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous systemVerena-Isabell Leussink, Mark Stettner, Clemens Warnke, et al.Neurology Research International|April 4, 2019
Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia GravisOliver Neuhaus, Karl-Heinz Wiesmüller, Hans-Peter Hartung, et al.Current Opinion in Neurology|May 15, 2007
Treatment and treatment trials in multiple sclerosisBernd C Kieseier, Heinz Wiendl, Bernhard Hemmer, et al.Qatar Medical Journal|November 29, 2023
Immunomodulatory potential of anti-IFN-beta antibodies on monocyte-derived macrophagesAjith Sominanda, Til Menge, Hans Peter Hartung, et al.Current Opinion in Neurology|May 14, 2005
Chronic inflammatory demyelinating polyneuropathy--update on pathogenesis, diagnostic criteria and therapyHubertus Köller, Michael Schroeter, Bernd C Kieseier, et al.The Lancet. Neurology|May 26, 2004
Are statins a treatment option for multiple sclerosis?Oliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.Nature Clinical Practice. Neurology|April 6, 2007
From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerveGerd Meyer zu Hörste, Hans-Peter Hartung, Bernd C KieseierThe European Journal of Neuroscience|December 30, 2017
Altered motor plasticity in an acute relapse of multiple sclerosisIsabelle Wirsching, Mathias Buttmann, Thorsten Odorfer, et al.Pageof 68